Alliancebernstein L.P. Acadia Pharmaceuticals Inc Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 147,480 shares of ACAD stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,480

Previous 147,881 0.27%

Holding current value

$2.31 Million

Previous $2.73 Million 12.36%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $5,862 - $7,386	-401 Reduced 0.27%	147,480 $2.4 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $304,209 - $527,706	17,100 Added 13.08%	147,881 $2.73 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $10,805 - $16,520	-520 Reduced 0.4%	130,781 $4.09 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $1.27 Million - $2.04 Million	-60,810 Reduced 31.65%	131,301 $2.74 Million
Q2 2023 Aug 15, 2023	BUY	$17.8 - $25.65 $710,398 - $1.02 Million	39,910 Added 26.22%	192,111 $4.6 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $816,000 - $1.05 Million	-50,000 Reduced 24.73%	152,201 $2.86 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $710,000 - $931,500	50,000 Added 32.85%	202,201 $3.22 Million
Q3 2022 Nov 15, 2022	SELL	$14.11 - $18.27 $244,103 - $316,071	-17,300 Reduced 10.21%	152,201 $2.49 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $206,859 - $432,798	15,900 Added 10.35%	169,501 $2.39 Million
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $1.04 Million - $1.37 Million	-49,649 Reduced 24.43%	153,601 $3.72 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $1.24 Million - $2 Million	-73,800 Reduced 26.64%	203,250 $4.74 Million
Q3 2021 Nov 10, 2021	BUY	$15.78 - $24.77 $1.94 Million - $3.04 Million	122,660 Added 79.45%	277,050 $4.6 Million
Q2 2021 Jul 30, 2021	BUY	$19.4 - $27.42 $1.35 Million - $1.91 Million	69,561 Added 82.0%	154,390 $3.77 Million
Q1 2021 May 06, 2021	SELL	$25.02 - $54.99 $684,772 - $1.51 Million	-27,369 Reduced 24.39%	84,829 $2.19 Million
Q4 2020 Feb 08, 2021	BUY	$41.04 - $56.79 $1.37 Million - $1.89 Million	33,299 Added 42.2%	112,198 $6 Million
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $468,761 - $733,647	-12,871 Reduced 14.03%	78,899 $3.26 Million
Q2 2020 Aug 13, 2020	SELL	$39.26 - $52.73 $5.89 Million - $7.91 Million	-149,999 Reduced 62.04%	91,770 $4.45 Million
Q1 2020 May 14, 2020	SELL	$31.65 - $46.87 $104,445 - $154,671	-3,300 Reduced 1.35%	241,769 $10.2 Million
Q4 2019 Feb 18, 2020	BUY	$36.21 - $51.4 $1.11 Million - $1.57 Million	30,580 Added 14.26%	245,069 $10.5 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $1.13 Million - $2.24 Million	50,790 Added 31.03%	214,489 $7.72 Million
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $226,204 - $272,764	9,700 Added 6.3%	163,699 $4.38 Million
Q1 2019 May 14, 2019	SELL	$16.17 - $27.38 $1.13 Million - $1.91 Million	-69,741 Reduced 31.17%	153,999 $4.14 Million
Q4 2018 Feb 13, 2019	BUY	$14.32 - $22.92 $1.11 Million - $1.77 Million	77,400 Added 52.89%	223,740 $3.62 Million
Q2 2018 Aug 13, 2018	BUY	$15.07 - $22.34 $689,362 - $1.02 Million	45,744 Added 45.47%	146,340 $2.24 Million
Q1 2018 May 14, 2018	BUY	$22.47 - $32.33 $51,883 - $74,649	2,309 Added 2.35%	100,596 $2.26 Million
Q4 2017 Feb 13, 2018	SELL	$26.84 - $39.14 $4,026 - $5,871	-150 Reduced 0.15%	98,287 $2.96 Million
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $2.9 Million - $3.78 Million	98,437	98,437 $3.71 Million

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.54B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Acadia Pharmaceuticals Inc Transaction History